A Study Evaluating the Safety and Efficacy of Venetoclax (GDC-0199) Plus Bendamustine + Rituximab (BR) in Comparison With BR or Venetoclax Plus Rituximab in Participants With Relapsed and Refractory Follicular Non-Hodgkin's Lymphoma (fNHL)

Cliniques Universitaires St-Luc, Brussels

Royal Prince Alfred Hospital; Medical Oncology, Camperdown

ZNA Stuivenberg, Antwerp

Royal North Shore Hospital, St Leonards

Westmead Hospital; Haematology, Sydney

St George Hospital, Kogarah, New South Wales

Calvary Mater Newcastle, Waratah

Monash Medical Centre, Clayton

Princess Alexandra Hospital, Woolloongabba

Townsville General Hospital, Douglas

Queen Elizabeth Hospital; Haematology, Woodville South

Royal Hobart Hospital, Hobart

AZ Sint Jan, Bruges

Azienda Ospedale San Giovanni, Turin

James P. Wilmot Cancer Center, Rochester

Allegheny General Hospital, Pittsburgh

University of Pittsburgh, Pittsburgh

University of Pennsylvania; School of Medicine, Philadelphia

Ospedale Niguarda Milano, Milan

CHU de Dijon - Hopital le Bocage, Dijon

University of Virginia, Charlottesville

Universitätsklinikum Schleswig-Holstein / Campus Lübeck, Med. Klinik I, Hämatologie/Onkologie, Lübeck

Asst Papa Giovanni XXIII, Bergamo

West Virginia Uni Med. Center - Robert Byrd Health Science, Morgantown

Irccs Policlinico San Matteo; Divisione Di Ematologia, Pavia

Nothwest Georgia Oncology Centers P.C, Austell

CHU Montpellier, Montpellier

Southern Cancer Center, PC, Mobile

A.O. Universitaria Policlinico S.Orsola-Malpighi Di Bologna, Bologna

Universitätsklinik Essen; Klinik und Poliklinik für Dermatologie, Venerologie und Allergologie, Essen

IRST Istituto Scientifico Romagnolo Per Lo Studio E Cura Dei Tumori, Sede Meldola; Oncologia Medica, Meldola

Ospedale Infermi di Rimini, Rimini

Ospedale di Ravenna, Ravenna

Institut de Cancerologie de l'Ouest, Angers

Az. Osp. Di Careggi; Divisione Di Ematologia, Florence

Universitätsklinikum Köln; Klinik I für Innere Medizin, Cologne

Uni. der Johannes Gutenberg-Universitaet Mainz; III. Medizinische Klinik und Poliklinik, Mainz

Primary Healthcare Associates SC - Harvey, Harvey

Northwestern University, Chicago

CHU Clermont Ferrand - Hôpital d'Estaing, Clermont-Ferrand

University of Kansas; Medical Center & Medical pavilion, Westwood

Centre Hospitalier Lyon Sud; Hematolgie, Pierre-Bénite

Centre Jean Bernard, Le Mans

Arizona Cancer Center, Tucson

Universitätsklinikum Ulm; Apotheke, Ulm

UCLA School of Medicine; Hematology/Oncology, Los Angeles

Hopital Henri Mondor, Créteil

Universitätsklinikum Würzburg; Medizinische Klinik und Poliklinik II; Hämatologie / Onkologie, Würzburg

University of Illinois at Chicago College of Medicine, Chicago

Sidney Kimmel Comp Cancer Ctr, Baltimore

Hackensack University Medical Center, Hackensack

VCU Massey Cancer Center, Richmond

Cross Cancer Institute, Edmonton

British Columbia Cancer Agency, Kelowna

University Health Network; Princess Margaret Hospital; Medical Oncology Dept, Toronto

Hopital Maisonneuve- Rosemont; Oncology, Montreal

Chum Hopital Notre Dame; Centre D'Oncologie, Montreal

Jewish General Hospital, Montreal

Saskatoon Cancer Centre; Uni of Saskatoon Campus, Saskatoon

Klinikum Chemnitz gGmbH; Klinik f. Innere Medizin III, Chemnitz

Städtisches Klinikum Dessau, Dessau

BAG Freiberg-Richter, Jacobasch, Illmer, Wolf; Gemeinschaftspraxis Hämatologie-Onkologie, Dresden

Universitätsklinikum Jena; Klinik für Innere Medizin II, Jena

Blackpool Victoria Hospital, Blackpool

St James University Hospital, Leeds

Leicester Royal Infirmary; Dept. of Medical Oncology, Leicester

University College London, Department of Haematology, London

Royal Marsden Nhs Trust; Consultant Cancer Physician, London

Christie Hospital; Breast Cancer Research Office, Manchester

Churchill Hospital; Oxford Cancer and Haematology Centre, Oxford

Royal Marsden NHS Foundation Trust, Sutton